hVIVO (LON:HVO) Trading Down 9.3% - Should You Sell?

hVIVO plc (LON:HVO - Get Free Report) shares traded down 9.3% on Monday . The stock traded as low as GBX 16.50 ($0.20) and last traded at GBX 16.51 ($0.20). 2,191,287 shares changed hands during mid-day trading, a decline of 3% from the average session volume of 2,269,521 shares. The stock had previously closed at GBX 18.20 ($0.22).

hVIVO Trading Down 9.3 %

The company has a market cap of £112.33 million, a PE ratio of 550.33 and a beta of 0.97. The stock's 50 day moving average is GBX 22.10 and its 200-day moving average is GBX 26.28. The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86.

About hVIVO

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.